SCHEMBL6630164

SCHEMBL6630164

NC(CS(=O)(=O)Cc1ccccc1)C(=O)NCCCC[C@@H](O)c1nc2ccccc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
MAPK1 P28482 1/20 0.45
LIPC P11150 11/20 0.42
LIPG Q9Y5X9 8/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6630166 1.00 HDAC6 (0.45) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6633338 0.86 MAPK1 (0.43) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6062888 0.86 MAPK1 (0.43) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6063224 0.86 HDAC3 (0.43) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6633085 0.86 HDAC3 (0.43) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6063017 0.86 MAPK1 (0.42) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6629203 0.86 MAPK1 (0.42) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6631489 0.82 HDAC3 (0.47) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6062081 0.81 HDAC3 (0.41) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6062076 0.81 HDAC3 (0.41) HDAC6HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed